You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced macular degeneration

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • IBI333
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Nov 28, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Faricimab PFS Configuration
  • Mesa, Arizona
  • +2 more
Jan 2, 2023

Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

Recruiting
  • Dry Age-related Macular Degeneration
  • Intravitreal injection of CB-PRP
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Age-related Macular Degeneration Trial in Boston (Omega-3 fatty acids (fish oil), Vitamin D3, Vitamin D3 )

Active, not recruiting
Has Results
  • Age-related Macular Degeneration
  • Omega-3 fatty acids (fish oil)
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 26, 2022

Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

Not yet recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • Non-invasive ultrasound retinal stimulation Device
  • (no location specified)
Jun 19, 2023

Age-Related Macular Degeneration Trial in Rotterdam (Standard lifestyle recommendations + dietary supplementation, Risk

Recruiting
  • Age-Related Macular Degeneration
  • Standard lifestyle recommendations + dietary supplementation
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Dec 19, 2022

Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • LX102-C01 Injection
  • Shanghai, China
    Shanghai General Hospital, Shanghai Jiao Tong University School
Apr 14, 2023

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

Not yet recruiting
  • Age Related Macular Degeneration (AMD)
  • SPIN
  • Non-aerobic, stretching/balance intervention Control
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023

Healthy, Macular Edema, Macular Degeneration Trial in Helsinki (ERG electrode tests for fundus image-guided focal ERG, Fundus

Completed
  • Healthy
  • +2 more
  • ERG electrode tests for fundus image-guided focal ERG
  • Fundus image-guided focal ERG
  • Helsinki, Uusimaa, Finland
    Helsinki University Hospital, Retinal Outpatient Clinic
Nov 7, 2022

Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Malvern, Victoria, Australia
  • +1 more
Apr 5, 2023

Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

Recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • i-Lumen(TM) AMD
  • i-Lumen(TM) AMD Sham
  • Phoenix, Arizona
  • +2 more
Sep 1, 2022

Data of Intravitreal Aflibercept Injection in Patients of Wet

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, India
    Many Locations
Feb 2, 2023

Therapy of Age-related Macular Degeneration

Recruiting
  • Age-Related Macular Degeneration
    • Ried Im Innkreis, Upperaustria, Austria
      BHS Ried
    Aug 16, 2022

    Optical Coherence Tomography and Microperimetry Biomarker

    Active, not recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • Natural history study
    • Basel, Basel-Stadt, Switzerland
      University Hospital Basel
    Jul 19, 2023

    Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • SKG0106
    • Katy, Texas
    • +1 more
    Aug 15, 2023

    Age-Related Macular Degeneration Trial in Hong Kong (Structured Light Imaging Microscopy)

    Recruiting
    • Age-Related Macular Degeneration
    • Structured Light Imaging Microscopy
    • Hong Kong, Guangdong, Hong Kong
      Centre for Eye and Vision Research Limited
    Jun 26, 2023

    Macular Degeneration (AMD) Post-marketing Surveillance in Japan

    Completed
    • Macular Degeneration
    • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Japan
      (unnamed)
    Jan 9, 2023

    Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
    • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
    • (no location specified)
    Jun 6, 2023

    Optical Coherence Tomography Angiography Criteria Of The

    Not yet recruiting
    • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
    • Optical coherence tomography angiography
    • (no location specified)
    Sep 27, 2022

    Intermediate Age-Related Macular Degeneration Trial in Peking (QA108 granules, QA108 granules )

    Recruiting
    • Intermediate Age-Related Macular Degeneration
    • QA108 granules
    • QA108 granules placebo
    • Peking, China
      Peking Union Medical College Hospital (PUMCH)
    Sep 28, 2022